214 related articles for article (PubMed ID: 34371870)
41. Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes.
Halper-Stromberg E; Gallo T; Champakanath A; Taki I; Rewers M; Snell-Bergeon J; Frohnert BI; Shah VN
J Clin Endocrinol Metab; 2020 Mar; 105(3):746-53. PubMed ID: 31676897
[TBL] [Abstract][Full Text] [Related]
42. Follow-Up of Bone Mineral Density Changes in de novo Kidney Transplant Recipients Treated with Two Doses of the Receptor Activator of Nuclear Factor κB Ligand Inhibitor Denosumab.
Kobel C; Frey D; Graf N; Wüthrich RP; Bonani M
Kidney Blood Press Res; 2019; 44(5):1285-1293. PubMed ID: 31614356
[TBL] [Abstract][Full Text] [Related]
43. Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.
Di Daniele N; Carbonelli MG; Candeloro N; Iacopino L; De Lorenzo A; Andreoli A
Pharmacol Res; 2004 Dec; 50(6):637-41. PubMed ID: 15501704
[TBL] [Abstract][Full Text] [Related]
44. Loss of bone mineral density and trabecular bone score in elderly hemodialysis patients: a 2-year follow-up, prospective, single-centre study.
Brunerová L; Kasalický P; Verešová J; Lažanská R; Potočková J; Rychlík I
Int Urol Nephrol; 2020 Feb; 52(2):379-385. PubMed ID: 32016906
[TBL] [Abstract][Full Text] [Related]
45. Individualized Fracture Risk Feedback and Long-term Benefits After 10 Years.
Wu F; Wills K; Laslett LL; Riley MD; Oldenburg B; Jones G; Winzenberg T
Am J Prev Med; 2018 Feb; 54(2):266-274. PubMed ID: 29246678
[TBL] [Abstract][Full Text] [Related]
46. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
[TBL] [Abstract][Full Text] [Related]
47. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.
Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525
[TBL] [Abstract][Full Text] [Related]
48. High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study.
Hutchins-Wiese HL; Picho K; Watkins BA; Li Y; Tannenbaum S; Claffey K; Kenny AM
Nutr Cancer; 2014; 66(1):68-76. PubMed ID: 24274259
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and safety of monthly ibandronate in men with low bone density.
Orwoll ES; Binkley NC; Lewiecki EM; Gruntmanis U; Fries MA; Dasic G
Bone; 2010 Apr; 46(4):970-6. PubMed ID: 20060082
[TBL] [Abstract][Full Text] [Related]
50. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
51. Bone volume, mineral density, and fracture risk after kidney transplantation.
Keronen S; Martola L; Finne P; Burton IS; Tong XF; Kröger H; Honkanen E
PLoS One; 2022; 17(3):e0261686. PubMed ID: 35349587
[TBL] [Abstract][Full Text] [Related]
52. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
53. Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol.
Evenepoel P; Claes K; Meijers B; Laurent MR; Bammens B; Naesens M; Sprangers B; Cavalier E; Kuypers D
Nephrol Dial Transplant; 2020 Apr; 35(4):697-705. PubMed ID: 30339234
[TBL] [Abstract][Full Text] [Related]
54. Effect of Vitamin B12 and Folic Acid Supplementation on Bone Mineral Density and Quantitative Ultrasound Parameters in Older People with an Elevated Plasma Homocysteine Level: B-PROOF, a Randomized Controlled Trial.
Enneman AW; Swart KM; van Wijngaarden JP; van Dijk SC; Ham AC; Brouwer-Brolsma EM; van der Zwaluw NL; Dhonukshe-Rutten RA; van der Cammen TJ; de Groot LC; van Meurs J; Lips P; Uitterlinden AG; Zillikens MC; van Schoor NM; van der Velde N
Calcif Tissue Int; 2015 May; 96(5):401-9. PubMed ID: 25712255
[TBL] [Abstract][Full Text] [Related]
55. Effect of Milk Powder Supplementation with Different Calcium Contents on Bone Mineral Density of Postmenopausal Women in Northern China: A Randomized Controlled Double-Blind Trial.
Chen Y; Xiao Y; Xie B; Zhang Q; Ma X; Li N; Liu M; Zhang Q
Calcif Tissue Int; 2016 Jan; 98(1):60-6. PubMed ID: 26438518
[TBL] [Abstract][Full Text] [Related]
56. Bone Benefits of Fish Oil Supplementation Depend on its EPA and DHA Content.
Abou-Saleh H; Ouhtit A; Halade GV; Rahman MM
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717258
[TBL] [Abstract][Full Text] [Related]
57. Dietary supplementation with highly purified eicosapentaenoic acid and docosahexaenoic acid does not influence PAI-1 activity.
Hansen J; Grimsgaard S; Nordoy A; Bonaa KH
Thromb Res; 2000 Apr; 98(2):123-32. PubMed ID: 10713313
[TBL] [Abstract][Full Text] [Related]
58. Intake of Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Mortality in Renal Transplant Recipients.
Gomes Neto AW; Sotomayor CG; Pranger IG; van den Berg E; Gans RO; Soedamah-Muthu SS; Navis GJ; Bakker SJ
Nutrients; 2017 Apr; 9(4):. PubMed ID: 28379169
[TBL] [Abstract][Full Text] [Related]
59. Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy.
Kalder M; Kyvernitakis I; Albert US; Baier-Ebert M; Hadji P
Osteoporos Int; 2015 Jan; 26(1):353-60. PubMed ID: 25381047
[TBL] [Abstract][Full Text] [Related]
60. Loss of bone mineral density in renal transplantation recipients.
Unal A; Kocyigit I; Sipahioglu MH; Tokgoz B; Kavuncuoglu F; Oymak O; Utas C
Transplant Proc; 2010 Nov; 42(9):3550-3. PubMed ID: 21094813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
